Although not enough data are available to call a winner just yet, we strongly believe that a next-generation agent that comes to the market well in advance of the competition will enjoy a strong foothold and will be difficult to overcome. However, we have seen the hepatitis C treatment space change dramatically within just a few short years and a similar revolution in the future is always a possibility.